News
MarketBeat on MSN46m
Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly
This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback